Sio Gene Therapies Inc (SIOX)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
David W. Nassif
Employees:
10
1501 BROADWAY, 12TH FLOOR, NEW YORK, NY, 10036
877-746-4891
Date | Ratio |
---|---|
2019-05-08 | 1:8 |
Sio Gene Therapies, Inc. focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. The company develops AXO-Lenti-PD, in vivo lentiviral gene therapy, which is in Phase II clinical trials for the treatment of Parkinson's disease.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|